Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cysteamine blocks amphetamine-induced deficits in sensorimotor gating

D Feifel1, K L Minor

  • 1Department of Psychiatry, University of California, San Diego, La Jolla 92093-8620, USA.

Pharmacology, Biochemistry, and Behavior
|November 5, 1997
PubMed
Summary

Cysteamine administration reversed amphetamine-induced deficits in sensorimotor gating, supporting a role for somatostatin in dopamine function. This suggests somatostatin may regulate gating, relevant to neuropsychiatric disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antipsychotic drug-like facilitation of latent inhibition by a brain-penetrating neurotensin-1 receptor agonist.

Journal of psychopharmacology (Oxford, England)·2016
Same author

Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugs.

Behavioural brain research·2014
Same author

Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.

Frontiers in neuroscience·2013
Same author

Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy.

Journal of psychopharmacology (Oxford, England)·2010
Same author

Sensorimotor gating in neurotensin-1 receptor null mice.

Neuropharmacology·2009
Same author

The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2009

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Somatostatin, a neuropeptide, interacts with dopamine.
  • Cysteamine selectively depletes somatostatin, serving as a tool to study its function.
  • Sensorimotor gating, measured by prepulse inhibition (PPI), is a key cognitive process.

Purpose of the Study:

  • To investigate the effects of cysteamine on baseline and amphetamine-disrupted sensorimotor gating.
  • To explore the role of endogenous somatostatin in regulating dopamine-related behaviors.
  • To assess the impact of cysteamine on the acoustic startle reflex.

Main Methods:

  • Administered subcutaneous cysteamine at various doses (50-300 mg/kg) to subjects.
  • Disrupted sensorimotor gating using systemic amphetamine (2 mg/kg).

Related Experiment Videos

  • Measured prepulse inhibition of the acoustic startle reflex to assess sensorimotor gating.

    • Main Results:

    • Cysteamine (50-300 mg/kg) reversed amphetamine-induced decreases in PPI.
    • Cysteamine did not affect the amplitude of the acoustic startle reflex.
    • The findings indicate a functional interaction between somatostatin and dopamine systems.

    Conclusions:

    • Endogenous somatostatin facilitates dopaminergic activity.
    • Somatostatin plays a significant role in regulating sensorimotor gating.
    • Deficient PPI is linked to neuropsychiatric conditions like schizophrenia, highlighting potential clinical relevance.